Onderzoeker
Ghesquiere Bart
- Disciplines (Flanders Institute for Biotechnology):Analyse van next-generation sequence data, Celdood, Kankerbiologie, (Bio)moleculaire modellering en design, Analytische biochemie, Auto-ecologie, Biogeografie en fylogeografie, Antropologische genetica, Bacteriologie, Celdood en senescentie, Epigenomics, Milieuveiligheid en gezondheid van nanotechnologie, Medische biofysica, Algemene diagnostiek, Adaptieve immunologie, Gedragsneurowetenschappen
- Disciplines (KU Leuven):Metabolomics, Scheidingstechnieken, Spectrometrie, Metabole regeling
- Zie ook: Bart Ghesquière (KU Leuven)
Affiliaties
- Metabolomics Expertisecentrum (VIB-KU Leuven) (Afdeling)
Verantwoordelijke
Vanaf1 okt 2016 → Heden - VIB Metabolomics Core Leuven (Core Labo)
Verantwoordelijke
Vanaf1 sep 2017 → Heden - VIB-KU Leuven Center for Cancer Biology (Onderzoekscentrum)
Verantwoordelijke
Vanaf1 sep 2017 → Heden - Ghesquière Lab (Onderzoeksgroep)
Verantwoordelijke
Vanaf1 sep 2017 → Heden - VIB Metabolomics Core Leuven (Core Labo)
Verantwoordelijke
Vanaf1 jan 2017 → Heden - Metabolomics Expertisecentrum (VIB-KU Leuven) (Afdeling)
Lid
Vanaf1 okt 2016 → 30 sep 2022 - Laboratorium voor Angiogenese en Vasculair Metabolisme (VIB-KU Leuven) (Afdeling)
Lid
Vanaf1 jan 2012 → 30 sep 2014
Projecten
1 - 5 of 5
- Tracer Raman-Driven Mass Spectrometry Imaging (TRaMaSI): a new platform for on-tissue Tracing of Nutritional and Biochemical Trajectories.Vanaf1 mei 2024 → HedenFinanciering: HORIZON.1.2 - Marie Skłodowska-Curie-acties (MSCA)
- VIB Grant for Ghesquière Lab_Period:2022-01-01-2026-12-31Vanaf1 jan 2022 → HedenFinanciering: VOI - Projectmatig onderzoek
- BE19-COMMUNITYLED (Bestaat uit de projecten GALAXY en PLANTS en gedeelte voor BaGh)Vanaf1 jun 2019 → 31 mei 2021Financiering: EMBL
- 'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’Vanaf1 jan 2018 → 20 mei 2024Financiering: Andere Eu-programma's en intiatieven
- VIB Grant for Ghesquière Lab_Period:2018-01-01-2021-12-31Vanaf1 jan 2018 → 31 dec 2021Financiering: VOI - Projectmatig onderzoek
Publicaties
1 - 10 van 82
- Neural and metabolic dysregulation in PMM2-deficient human in vitro neural models.(2024)
Auteurs: Karen Driesen, Bart Ghesquière
Pagina's: 113883 - Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance.(2024)
Auteurs: Tommaso Scolaro, Marta Manco, Rosa Trotta, Heleen Van Acker, Jan Daniluk, Donatella Ponti, Ginevra Doglioni, Juan Fernandez Garcia, Silvia Radenkovic, Mario di Matteo, et al.
Pagina's: e-pub - Glycosphingolipids in congenital disorders of glycosylation (CDG).(2024)
Auteurs: Andrea Jáñez Pedrayes, Bart Ghesquière
Pagina's: 108434 - MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy.(2024)
Auteurs: Bart Ghesquière
Pagina's: 217091 - Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure.(2024)
Auteurs: Silvia Radenkovic, Bram Boeckx, Mohammad Ghorbani, Diether Lambrechts, Bart Ghesquière
Pagina's: e-pub - Ischemia-induced Metabolic Patterns Associate With Kidney Function During Normothermic Kidney Perfusion: A Preclinical Study.(2024)
Auteurs: Julie De Beule, Laurence Verstraeten, Bart Ghesquière
Pagina's: 156-164 - ACSM1 and ACSM3 regulate fatty acid metabolism to support prostate cancer growth and constrain ferroptosis.(2024)
Auteurs: Bart Ghesquière
Pagina's: e-pub - Smad1/5 is acetylated in the dorsal aortae of the mouse embryo before the onset of blood flow, driving early arterial gene expression.(2024)
Auteurs: Colinda Scheele, Bart Ghesquière
Pagina's: e-pub - The gluconeogenesis enzyme PCK2 has a non-enzymatic role in proteostasis in endothelial cells.(2024)
Auteurs: Lucas Treps, Stefan Vinckier, Bart Ghesquière, Luc Schoonjans, Guy Eelen, Mieke Dewerchin, Peter Carmeliet
Pagina's: 618 - NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease.(2023)
Auteurs: Wesley Vermaelen, Bart Ghesquière, Peter Carmeliet
Pagina's: 998-1011
Patenten
1 - 5 van 5
- METHODS FOR ANALYZING THE PERFUSATE OF AN EX SITU MACHINE PERFUSED KIDNEY (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)